FIELD: biotechnology.
SUBSTANCE: described is a group of inventions involving a method for purifying matrix RNA (mRNA) (embodiments). In one embodiment, the method involves precipitation of mRNA in a suspension containing a high-molar salt solution and an amphiphilic polymer to obtain a precipitated mRNA; capture of precipitated mRNA; washing the precipitated mRNA with a washing solution with purifying the precipitated mRNA and solubilising the precipitated mRNA to obtain a purified mRNA.
EFFECT: invention extends the range of methods for purifying matrix RNA (mRNA).
31 cl, 18 dwg, 8 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| mRNA PURIFICATION BY TANGENTIAL FLOW FILTRATION | 2020 |
|
RU2810003C2 |
| SCALE PRODUCTION METHOD OF PRODUCING RECOMBINANT LENTIVIRAL VECTORS IN CELL CULTURE SYSTEM IN SERUM-FREE SUSPENSION | 2014 |
|
RU2709678C2 |
| MEANS FOR IMPROVEMENT OF GENE SILENCING OR ITS CHARACTERISTICS | 2017 |
|
RU2775479C2 |
| METHODS FOR OBTAINING SINGLE-STRANDED RNA | 2017 |
|
RU2760790C2 |
| METHOD OF PRODUCING IGG COMPOSITION BY THERMAL PROCESSING | 2013 |
|
RU2636049C2 |
| METHOD OF PRODUCING IMMUNOGLOBULINS | 2016 |
|
RU2708394C2 |
| COMPOSITIONS CONTAINING SUPER-HYDROPHILIC-AMPHIPHILIC COPOLYMERS AND METHODS FOR USE THEREOF | 2010 |
|
RU2589836C2 |
| METHOD OF OBTAINING PEGYLATED OLIGONUCLEOTIDES | 2012 |
|
RU2564855C2 |
| COMPLEMENT-BINDING APTAMERS AND C5 AGENTS APPLICABLE FOR TREATING OCULAR DISORDERS | 2007 |
|
RU2477137C2 |
| METHOD OF MICROPARTICLE FORMATION | 2008 |
|
RU2521388C2 |
